AMGN vs HSIC · P/E 24, rev $10.05B vs P/E 24, rev $6.83B
Amgen Inc (AMGN) versus Henry Schein Inc (HSIC) — a side-by-side from cached financials, not a winner call.
Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
Henry Schein Inc (HSIC) is a medical distribution company listed on NASDAQ.
Latest reported AMGN revenue for 2026-06-30 was $10.05B. Net income was $2.38B. Revenue was up 16.7% from 2026-03-31 to 2026-06-30. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
Latest reported HSIC revenue for 2026-06-27 was $6.83B. Net income was $201.0M. HSIC currently screens at market cap $9.11B and trailing P/E 24.2.
AMGN currently screens at market cap $188.67B and trailing P/E 24.3. HSIC currently screens at market cap $9.11B and trailing P/E 24.2.
Not investment advice. Open the AMGN and HSIC stock pages for the full models.
Not investment advice.